[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567583":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":19,"locations":25,"responsibleParty":43,"collaborators":11,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":11,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":11,"enrollmentInfo":54,"targetDuration":11,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":11,"overallStatus":27,"whyStopped":11,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University of Vermont","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Prolonged exposure therapy + incentives for therapy session attendance","EXPERIMENTAL",null,[13],"Behavioral: Prolonged exposure therapy + incentives for therapy session attendance",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"BEHAVIORAL","Prolonged exposure therapy plus incentives for therapy session attendance",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":11,"email":24},"Kelly Peck, PhD","CONTACT","802-656-9610","kelly.peck@uvm.edu",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Burlington","Vermont","05401","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-73.21207,44.47588,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":42,"phoneExt":11,"email":24},"Kelly Peck","8026569610",{"type":44,"investigatorFullName":41,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Professor","100567583","prolonged-exposure-therapy-to-treat-posttraumatic-stress-disorder-in-pregnant-patients-100567583",false,"NCT06670079","Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients","Inclusion Criteria:\n\n* Female\n* \\>18 years old\n* Gestational age ≤ 25 weeks\n* Meet current DSM-5 posttraumatic stress disorder criteria based on the Clinician Administered PTSD Scale for DSM-5\n* Participants receiving psychotropic medications must be maintained on a stable dose for \\>14 days prior to enrollment.\n\nExclusion Criteria:\n\n* Male\n* Under 18 years old\n* Gestational age \\> 25 weeks\n* No current diagnosis of PTSD\n* Current delusions or hallucinations, unstable bipolar disorder, imminent risk for suicide as assessed by the Mini International Neuropsychiatric Interview\n* Enrolled in another ongoing evidence-based treatment for PTSD.","FEMALE","18 Years",{"count":55,"type":56},30,"ESTIMATED","INTERVENTIONAL",[59],"NA","The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is:\n\nDoes PE+ decrease PTSD symptoms?\n\nAll participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning.\n\nParticipants will:\n\n* Receive individual PE+ therapy for 1 hour weekly for 12 weeks.\n* Receive financial incentives for attending each PE+ session.\n* Attend assessment visits every 4 weeks for the 12 weeks of the trial.\n* Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.",[62,63],"Posttraumatic Stress Disorder","Pregnancy","2026-05-08",{"date":66,"type":67},"2026-05-13","ACTUAL",{"date":69,"type":67},"2026-02-05",{"date":71,"type":56},"2027-07-22",{"name":5,"class":6},1]